Ss Innovations International Inc. (SSII)
NASDAQ (CM) NASDAQ (CM) Primary 
SS Innovations Announces Chief Financial Officer Transition
FORT LAUDERDALE, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Arvind Palaniappan as the Company's Interim Chief Financial Officer, effective May 1, 2025, pursuant to a planned leadership transition.
SS Innovations Announces Chief Financial Officer Transition
Listened: Thomas Wolff · SS Innovations Announces Chief Financial Officer Transition Fort Lauderdale, FL, May 2, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations to Uplist to Nasdaq
Listened: Fort Lauderdale, FL, April 24, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations to Uplist to Nasdaq
FORT LAUDERDALE, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company's common stock has been approved for listing on The Nasdaq Capital Market® (“Nasdaq”).
SS Innovations Achieves Significant Milestones in 2024
FORT LAUDERDALE, FL, March 31, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine
Fort Lauderdale, Fla. March 28, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine
FORT LAUDERDALE, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, has received regulatory approvals for its SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine.
SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System
The SSI Mantra 3 Surgical Robotic System enabled a seamless connection from SS Innovations headquarters in Gurugram, India to Aster CMI Hospital in Bengaluru, India covering a distance over 2,000 km. The SSi Mantra, India's first CDSCO*-approved surgical robotic system for telesurgery, brings precision and accessibility to complex surgical procedures.
SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System
Fort Lauderdale, FL, March 27, 2025 – PRISM MediaWire – SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative robotic surgical technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, announced that it successfully performed India's first North-to-South robotic cardiac telesurgery.
SS Innovations International Performs World's First Robotic Cardiac Telesurgeries with its SSi Mantra 3
Fort Lauderdale, Fla., January 13, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting
FORT LAUDERDALE, Fla., Dec. 11, 2024 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting
FORT LAUDERDALE, Fla., Dec. 11, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today announced that its new independent registered public accounting firm, BDO India LLP (“BDO”), has completed the re-audit of the Company's consolidated financial statements for the years ended December 31, 2023 and December 31, 2022, which were included in the Company's previously filed Annual Report on Form 10-K for the year ended December 31, 2023 (the “Original Filing”).
